Frederick A. Boop - Concepedia

Author

Frederick A. Boop

St. Jude Children's Research Hospital ORCID

Also Known As

F A Boop, F Boop, F. A. BOOP, F. A. Boop, F. Boop, F.A. Boop, Frederick A Boop, Frederick A. Boop, Frederick Boop, G. Armstrong

406

Publications

15.3K

Citations

H-Index

214

Concepts

All Affiliations

St. Jude Children's Research Hospital University of Tennessee Health Science Center Le Bonheur Children's Hospital Semmes Murphey Foundation University of Arkansas for Medical Sciences

About

Frederick A. Boop is an author at St. Jude Children's Research Hospital specializing in medicine, neuro-oncology, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	97	5.8K
2	Health Sciences	21	28	1K
3	Social Sciences	8	8	434
4	Engineering	3	3	80
5	Language Studies	1	1	93

Frederick A. Boop

190

Publications

12.6K

Citations

H-Index

Page 1

	Year	Citations
Subtypes of medulloblastoma have distinct developmental origins Paul Gibson, Yiai Tong, Giles Robinson, Nature Developmental BiologyProtistDistinct Developmental OriginsGenetic DisorderHistopathology	2010	817
Randomized Trial of Cerebrospinal Fluid Shunt Valve Design in Pediatric Hydrocephalus James M. Drake, John R. W. Kestle, Ruth Milner, Neurosurgery	1998	693
C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma Matthew Parker, Kumarasamypet M. Mohankumar, Chandanamali Punchihewa, Nature MedicineImmunologyC11orf95–rela FusionsCancer GeneticsCancer Biology	2014	661
Global neurosurgery: the current capacity and deficit in the provision of essential neurosurgical care. Executive Summary of the Global Neurosurgery Initiative at the Program in Global Surgery and Social Change Michael C. Dewan, Abbas Rattani, Graham Fieggen, Journal of neurosurgery	2018	578
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma Paul A. Northcott, Yukiko Nakahara, Xiaochong Wu, Nature Genetics Histone ModificationsChromatinHistone Lysine MethylationChromatin RemodelingGenetic Disorder	2009	415
Long-Term Follow-Up Data from the Shunt Design Trial John Kestle, James M. Drake, Ruth Milner, Pediatric Neurosurgery	2000	414
Preliminary Results From a Phase II Trial of Conformal Radiation Therapy and Evaluation of Radiation-Related CNS Effects for Pediatric Patients With Localized Ependymoma Thomas E. Merchant, Raymond K. Mulhern, Matthew J. Krasin, Journal of Clinical Oncology	2004	309
Lack of benefit of endoscopic ventriculoperitoneal shunt insertion: a multicenter randomized trial John R. W. Kestle, James M. Drake, D. Douglas Cochrane, Journal of neurosurgery	2003	227
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03) Amar Gajjar, Giles Robinson, Kyle Smith, Journal of Clinical Oncology	2021	217
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial Giles Robinson, Vasilisa A. Rudneva, Ivo Buchhalter, The Lancet Oncology Neuro-oncologyOncologyRisk-adapted TherapyPediatric HematologyClinical Trials	2018	216

Page 1